2015-06 | An early endosome regulator, Rab5b, is an LRRK2 kinase substrate | 서혜명 |
2008-06 | Effects of Olanzapine on Gene Expression Changes in MK-801-induced Neurotoxicity Using a High-density DNA Microarray | 서혜명 |
2007-12 | Effects of olanzapine on gene MK-801-induced neurotoxicity expression changes in using a high-density DNA microarray | 서혜명 |
2007-02 | Efficient Induction of Oligodendrocytes from Human Embryonic Stem Cells | 서혜명 |
2015-08 | Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease | 서혜명 |
2013-11 | EPITRANS: A database that integrates epigenome and transcriptome data | 서혜명 |
2017-10 | Erratum: Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression (Molecular brain (2015) 8 (54)) | 서혜명 |
2016-04 | G2385R and I2020T Mutations Increase LRRK2 GTPase Activity | 서혜명 |
2016-05 | GENE THERAPY BY PROTEASOME ACTIVATOR, PA28 gamma, IMPROVES MOTOR COORDINATION AND PROTEASOME FUNCTION IN HUNTINGTON'S DISEASE YAC128 MICE | 서혜명 |
2004-09 | Generalized brain and skin proteasome inhibition in Huntington's disease | 서혜명 |
2004-09 | Generalized brain and skin proteasome inhibition in huntington`s disease | 서혜명 |
2019-08 | HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice | 서혜명 |
2015-10 | High DJ-1 level in urine exosome of Koreans with Parkinson's disease | 서혜명 |
2020-01 | Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models | 서혜명 |
2013-03 | Identification of cancer-specific biomarkers by using microarray gene expression profiling | 서혜명 |
2018-09 | Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity | 서혜명 |
2014-11 | Increased DJ-1 in Urine Exosome of Korean Males with Parkinson's Disease | 서혜명 |
2015-10 | Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease | 서혜명 |
2020-03 | Iroquois homeobox protein 2 identified as a potential biomarker for Parkinson's disease | 서혜명 |
2014-11 | JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells | 서혜명 |
2015-09 | Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression | 서혜명 |
2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation | 서혜명 |
2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase3 and histone deacetylation. | 서혜명 |
2015-09 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase | 서혜명 |
2013-08 | LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25 | 서혜명 |
2021-09 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice | 서혜명 |
2021-05 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2G2019S Parkinson's Disease Model Mice | 서혜명 |
2014-07 | miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling | 서혜명 |
2016-01 | MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons | 서혜명 |
2021-03 | Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model | 서혜명 |